Impact of allergies on survival outcomes in NSCLC

Allergy evidence from unstructured clinical notes is associated with improved NSCLC survival

INDICATION
Lung

Kaplan-Meier survival curve comparing two groups, showing median survival and a significant p-value.
Kaplan-Meier survival curves comparing rwOS between NSCLC patients with (‘Yes’) or without (‘No’) evidence of allergies. Analysis is conducted on pre-treatment samples and anchored at 1L treatment start. Shaded areas represent the 95% confidence intervals. Patient counts and median survival times are specified.

Related cases

Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Grid displaying data points with blue, black, and gray squares on a white background.

RB1 loss-of-function mutations in post-Osimertinib NSCLC and prognostic implications

2026-07-01
Lung
RB1
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Abstract grid of small blue, gray, black, and orange squares on a white background.

Tracking PPM1D post-treatment prevalence to evaluate prognosis in lung adenocarcinoma

2026-07-01
Lung
PPM1D
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Pixelated diagonal gradient with bands of purple, blue, and green dots, resembling data visualization.

PRAME expression and histology impact survival in first-line NSCLC

2026-05-26
Lung
PRAME